Unknown NA INTERVENTIONAL 1-arm NCT03176342

Drug Patch Tests in Patients With Severe Cutaneous Adverse Reaction to Drugs (SCARs)

Drug Patch Tests, Enzyme-linked Immunosorbent Spot Assay (Elispot) and Lymphocyte Transformation Tests in Patients With Severe Cutaneous Adverse Reaction to Drugs (SCARs)

Sponsor: Chulalongkorn University

Conditions Drug Reaction

Interventions patch test

Updated 6 times since 2017 Last updated: Jun 3, 2017 Started: Aug 4, 2016 Primary completion: Aug 3, 2017 Completion: Aug 3, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03176342, this NA trial focuses on Drug Reaction and remains ongoing. Sponsored by Chulalongkorn University, it has been updated 6 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jul 2019 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jun 2018 — Jul 2019 [monthly]

Recruiting NA

▶ Show 1 earlier version

Jul 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Aug 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chulalongkorn University

Data source: Chulalongkorn University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bangkok, Thailand